Clinical Trial Update: Arginine Therapy for Sickle Cell Disease Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating arginine therapy for pain in sickle cell disease has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Vaso-occlusive Pain Episode

Drugs mentioned

• Arginine therapy (Arginine)

Snippet

Sponsor: Emory University | Conditions: Sickle Cell Disease, Vaso-occlusive Pain Episode | Phase 2 | Status: COMPLETED | Results posted: 2022-06-06